The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 163:1276-1279, July 2006
doi: 10.1176/appi.ajp.163.7.1276
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Bai, Y. M.
* Articles by Chou, P.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Bai, Y. M.
* Articles by Chou, P.
Related Collections
* Atypical Neuroleptics

Brief Report

Association of Initial Antipsychotic Response to Clozapine and Long-Term Weight Gain

Ya Mei Bai, M.D., Chao-Cheng Lin, Jen-Yeu Chen, Chih-Yuan Lin, M.D., Tung-Ping Su, M.D., and Pesus Chou, Ph.D.

OBJECTIVE: The aim of this study was to test whether the initial antipsychotic response to clozapine is related to subsequent weight change. METHOD: This study was an 8-year retrospective chart review of 96 hospitalized patients with schizophrenia. Data on monthly weight change, initial clinical response, age, gender, clozapine dose, and concomitant use of mood stabilizers and other antipsychotics were analyzed. RESULTS: Fifty-five (57.3%) of the patients received clozapine over the entire 8-year period; these subjects experienced an average weight gain of 11.7 kg (SD=1.6). Seventeen of these patients (30.9%) who had a significant initial clinical response (CGI improvement rating of 1 or 2 during the first 14 months) gained significantly more weight (13.8 kg [SD=8.4]) than did the 38 patients without a significant initial response (4.5 kg [SD=12.0]). Multiple linear regression analysis showed significant initial clinical response and lower baseline body mass index were associated with significantly more weight gain. CONCLUSIONS: The results show that initial antipsychotic response to clozapine is associated with subsequent long-term weight gain as measured over 8 years.




This article has been cited by other articles:


Home page
Evid. Based Ment. HealthHome page
R. van Winkel and M. De Hert
Incidence of schizophrenia lower in people with type I diabetes
Evid. Based Ment. Health, May 1, 2008; 11(2): 63 - 63.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org